MP41-07 COULD ADJUVANT CHEMOTHERAPY HAVE ADDITIONAL THERAPEUTIC BENEFIT IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY?

Autor:	Koichiro Ogihara, Keishiro Fukumoto, Kunimitsu Kanai, Eiji Kikuchi, Kyohei Hakozaki, Nobuyuki Tanaka, Suguru Shirotake, Yasumasa Miyazaki, Minami Omura, Mototsugu Oya, Gou Kaneko, Kazuhiro Matsumoto
Rok vydání:	2018
Předmět:	Oncology Cystectomy medicine.medical_specialty Chemotherapy Bladder cancer Adjuvant chemotherapy business.industry Urology medicine.medical_treatment Internal medicine medicine medicine.disease business
Zdroj:	Journal of Urology. 199
ISSN:	1527-3792 0022-5347
DOI:	10.1016/j.juro.2018.02.1294
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6271d79d656dff940e1dccdc7989d63f https://doi.org/10.1016/j.juro.2018.02.1294 Zobrazit plný text záznamu